CMOPF
Price
$64.37
Change
+$9.37 (+17.04%)
Updated
May 28 closing price
Capitalization
827.91M
GIFLF
Price
$11.45
Change
-$0.85 (-6.91%)
Updated
Jun 23 closing price
Capitalization
8.78B
Interact to see
Advertisement

CMOPF vs GIFLF

Header iconCMOPF vs GIFLF Comparison
Open Charts CMOPF vs GIFLFBanner chart's image
Cosmo Pharmaceuticals
Price$64.37
Change+$9.37 (+17.04%)
Volume$200
Capitalization827.91M
Grifols Sa
Price$11.45
Change-$0.85 (-6.91%)
Volume$1.22K
Capitalization8.78B
CMOPF vs GIFLF Comparison Chart in %
Loading...
CMOPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GIFLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CMOPF vs. GIFLF commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMOPF is a Hold and GIFLF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (CMOPF: $64.37 vs. GIFLF: $11.45)
Brand notoriety: CMOPF and GIFLF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: CMOPF: 100% vs. GIFLF: 95%
Market capitalization -- CMOPF: $827.91M vs. GIFLF: $8.78B
CMOPF [@Pharmaceuticals: Major] is valued at $827.91M. GIFLF’s [@Pharmaceuticals: Major] market capitalization is $8.78B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMOPF’s FA Score shows that 1 FA rating(s) are green whileGIFLF’s FA Score has 1 green FA rating(s).

  • CMOPF’s FA Score: 1 green, 4 red.
  • GIFLF’s FA Score: 1 green, 4 red.
According to our system of comparison, GIFLF is a better buy in the long-term than CMOPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMOPF’s TA Score shows that 4 TA indicator(s) are bullish while GIFLF’s TA Score has 4 bullish TA indicator(s).

  • CMOPF’s TA Score: 4 bullish, 2 bearish.
  • GIFLF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, CMOPF is a better buy in the short-term than GIFLF.

Price Growth

CMOPF (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while GIFLF (@Pharmaceuticals: Major) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.19%. For the same industry, the average monthly price growth was +2.56%, and the average quarterly price growth was +9.33%.

Industries' Descriptions

@Pharmaceuticals: Major (+1.19% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GIFLF($8.79B) has a higher market cap than CMOPF($828M). CMOPF has higher P/E ratio than GIFLF: CMOPF (68.49) vs GIFLF (62.50). GIFLF YTD gains are higher at: 19.895 vs. CMOPF (-3.818). GIFLF has higher annual earnings (EBITDA): 726M vs. CMOPF (42.1M). GIFLF has more cash in the bank: 557M vs. CMOPF (222M). CMOPF has less debt than GIFLF: CMOPF (176M) vs GIFLF (10.9B). GIFLF has higher revenues than CMOPF: GIFLF (6.46B) vs CMOPF (104M).
CMOPFGIFLFCMOPF / GIFLF
Capitalization828M8.79B9%
EBITDA42.1M726M6%
Gain YTD-3.81819.895-19%
P/E Ratio68.4962.50110%
Revenue104M6.46B2%
Total Cash222M557M40%
Total Debt176M10.9B2%
FUNDAMENTALS RATINGS
CMOPF vs GIFLF: Fundamental Ratings
CMOPF
GIFLF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
19
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8987
PRICE GROWTH RATING
1..100
6146
P/E GROWTH RATING
1..100
9797
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CMOPF's Valuation (15) in the null industry is in the same range as GIFLF (19). This means that CMOPF’s stock grew similarly to GIFLF’s over the last 12 months.

CMOPF's Profit vs Risk Rating (100) in the null industry is in the same range as GIFLF (100). This means that CMOPF’s stock grew similarly to GIFLF’s over the last 12 months.

GIFLF's SMR Rating (87) in the null industry is in the same range as CMOPF (89). This means that GIFLF’s stock grew similarly to CMOPF’s over the last 12 months.

GIFLF's Price Growth Rating (46) in the null industry is in the same range as CMOPF (61). This means that GIFLF’s stock grew similarly to CMOPF’s over the last 12 months.

GIFLF's P/E Growth Rating (97) in the null industry is in the same range as CMOPF (97). This means that GIFLF’s stock grew similarly to CMOPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CMOPFGIFLF
RSI
ODDS (%)
Bearish Trend 6 days ago
38%
Bearish Trend 3 days ago
56%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
20%
Bullish Trend 3 days ago
49%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
6%
Bearish Trend 3 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
23%
Bullish Trend 3 days ago
43%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
23%
Bullish Trend 3 days ago
41%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
68%
Aroon
ODDS (%)
Bullish Trend 3 days ago
25%
Bullish Trend 3 days ago
26%
View a ticker or compare two or three
Interact to see
Advertisement
CMOPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GIFLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLRRX12.230.15
+1.24%
NYLI Winslow Large Cap Growth Class R1
JIISX82.190.70
+0.86%
JPMorgan US Sustainable Leaders I
PORIX60.580.36
+0.60%
Trillium ESG Global Equity Institutional
FIJDX38.850.22
+0.57%
Fidelity Advisor Gold Z
UEIPX14.470.06
+0.42%
UBS Engage For Impact P

CMOPF and

Correlation & Price change

A.I.dvisor tells us that CMOPF and CHGCF have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CMOPF and CHGCF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMOPF
1D Price
Change %
CMOPF100%
N/A
CHGCF - CMOPF
10%
Poorly correlated
-9.99%
CHGCY - CMOPF
5%
Poorly correlated
-0.89%
BAYZF - CMOPF
2%
Poorly correlated
-0.90%
GIFLF - CMOPF
1%
Poorly correlated
N/A
CHJTF - CMOPF
-0%
Poorly correlated
N/A
More

GIFLF and

Correlation & Price change

A.I.dvisor tells us that GIFLF and GIFOF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GIFLF and GIFOF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GIFLF
1D Price
Change %
GIFLF100%
N/A
GIFOF - GIFLF
30%
Poorly correlated
N/A
BAYZF - GIFLF
10%
Poorly correlated
-0.90%
DSNKY - GIFLF
7%
Poorly correlated
-2.41%
CSPCY - GIFLF
7%
Poorly correlated
+4.50%
DSKYF - GIFLF
6%
Poorly correlated
-2.39%
More